Michele Kaloss
- Genetics top 5%
- Molecular Biology
- Oncology top 10%
- Infectious Diseases top 10%
- Biotechnology top 10%
- Co-authors
- Michael KalekoNeeraja IdamakantiTheodore A SmithSusan C. StevensonSheila ConnellyArthur W. NienhuisShanthi GaneshP. Seshidhar Reddy
- Topics
- Virus-based gene therapy research (12 papers)CAR-T cell therapy research (5 papers)CRISPR and Genetic Engineering (4 papers)
- Cited by
- GeneticsOncologyBiotechnology
- Partner nations
- United StatesSwitzerland
In The Last Decade
Michele Kaloss
15 papers receiving 797 citations
Peers
Comparison fields: 5 of 53
- Genetics 704
- Molecular Biology 602
- Oncology 280
- Infectious Diseases 159
- Biotechnology 82
Countries citing papers authored by Michele Kaloss
This map shows the geographic impact of Michele Kaloss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michele Kaloss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michele Kaloss more than expected).
Fields of papers citing papers by Michele Kaloss
This network shows the impact of papers produced by Michele Kaloss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michele Kaloss. The network helps show where Michele Kaloss may publish in the future.
Co-authorship network of co-authors of Michele Kaloss
This figure shows the co-authorship network connecting the top 25 collaborators of Michele Kaloss. A scholar is included among the top collaborators of Michele Kaloss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michele Kaloss. Michele Kaloss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 36 | |
| 2 | 108 | |
| 3 | 98 | |
| 4 | An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy. | 83 |
| 5 | 89 | |
| 6 | 103 | |
| 7 | 37 | |
| 8 | 71 | |
| 9 | 36 | |
| 10 | 7 | |
| 11 | 18 | |
| 12 | 16 | |
| 13 | 4 | |
| 14 | An improved retroviral vector encoding the herpes simplex virus thymidine kinase gene increases antitumor efficacy in vivo. | 33 |
| 15 | 85 |
About Michele Kaloss
Michele Kaloss is a scholar working on Genetics, Biotechnology and Oncology, having authored 15 papers that have together received 824 indexed citations. Recurring topics across this work include Virus-based gene therapy research (12 papers), CAR-T cell therapy research (5 papers) and CRISPR and Genetic Engineering (4 papers). The work is most often cited by research in Genetics (704 citations), Oncology (280 citations) and Biotechnology (82 citations). Michele Kaloss has collaborated with scholars based in United States and Switzerland. Frequent co-authors include Michael Kaleko, Neeraja Idamakanti, Theodore A Smith, Susan C. Stevenson, Sheila Connelly, Arthur W. Nienhuis, Shanthi Ganesh, P. Seshidhar Reddy, Elio F. Vanin and Laura A. King. Their work appears in journals such as Nature Biotechnology, Journal of Virology and Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.